Michael Gelband’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.44M Buy
93,353
+62,880
+206% +$6.51M 0.06% 308
2026
Q1
$2.95M Buy
30,473
+20,502
+206% +$2.1M 0.02% 622
2025
Q4
$1.06M Sell
9,971
-8,764
-47% -$1.02M 0.01% 979
2025
Q3
$2.38M Buy
18,735
+11,497
+159% +$1.37M 0.02% 680
2025
Q2
$888K Buy
+7,238
New +$827K 0.01% 991
2025
Q1
Sell
-67,870
Closed -$6.27M 1600
2024
Q4
$6.27M Buy
+67,870
New +$6.66M 0.04% 386
2024
Q3
Sell
-14,649
Closed -$1.26M 1735
2024
Q2
$1.26M Sell
14,649
-64,564
-82% -$5.42M 0.01% 943
2024
Q1
$6.54M Buy
+79,213
New +$5.8M 0.05% 318
2023
Q4
Sell
-9,663
Closed -$649K 1612
2023
Q3
$649K Buy
+9,663
New +$665K 0.01% 1148
2023
Q2
Sell
-57,117
Closed -$3.09M 1946
2023
Q1
$3.09M Buy
+57,117
New +$3.32M 0.03% 707
2022
Q3
Sell
-4,499
Closed -$201K 1984
2022
Q2
$201K Sell
4,499
-2,162
-32% -$111K ﹤0.01% 1658
2022
Q1
$377K Sell
6,661
-27,851
-81% -$1.45M ﹤0.01% 1672
2021
Q4
$1.79M Sell
34,512
-111,673
-76% -$5.76M 0.02% 805
2021
Q3
$8.73M Buy
146,185
+84,874
+138% +$5.34M 0.12% 225
2021
Q2
$3.81M Buy
+61,311
New +$4.09M 0.04% 453
2021
Q1
Sell
-20,243
Closed -$1.33M 2226
2020
Q4
$1.33M Buy
20,243
+10,188
+101% +$599K 0.01% 713
2020
Q3
$520K Sell
10,055
-38,719
-79% -$1.99M 0.01% 989
2020
Q2
$2.4M Buy
+48,774
New +$2.63M 0.06% 359
2020
Q1
Sell
-19,125
Closed -$1.05M 1213
2019
Q4
$1.05M Buy
+19,125
New +$1.04M 0.02% 532

Other funds holding EHC

Michael Gelband's EHC Position: Q2 2026 in Review

Michael Gelband increased its Encompass Health (EHC) stake by 206% in Q2 2026, buying an estimated $6.51M and bringing the position to 93,353 shares worth $9.44M. The position accounts for 0.06% of the portfolio, ranked #308.

Michael Gelband first reported a position in EHC in Q4 2019 and has held it in 19 quarters since. 594 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Michael Gelband held 93,353 shares of Encompass Health worth $9.44M as of Q2 2026.
  • Michael Gelband bought 62,880 Encompass Health shares in Q2 2026, an estimated $6.51M.
  • Encompass Health made up 0.06% of Michael Gelband's portfolio in Q2 2026, its #308 holding.
  • Michael Gelband first reported a position in Encompass Health in Q4 2019 and has held it in 19 quarters since.
  • 594 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.